Combining antigen-specific T cells with T-cell engager therapy induces a molecular signature that favors T-cell fitness
Open Access
- 2 May 2025
- journal article
- Published by Elsevier in Blood Immunology & Cellular Therapy
- Vol. 1 (1)
Abstract
No abstract availableKeywords
Funding Information
- Hackensack Meridian Health
- Children's Leukemia Research Association
- National Cancer Institute
This publication has 49 references indexed in Scilit:
- Proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1) controls immune synapse stability in human T cellsJournal of Allergy and Clinical Immunology, 2018
- The Ciliary Machinery Is Repurposed for T Cell Immune Synapse Trafficking of LCKDevelopmental Cell, 2018
- Androgen-inducible gene 1 increases the ER Ca2+ content and cell death susceptibility against oxidative stressGene, 2016
- Genetic and Epigenetic Regulation of PD-1 ExpressionThe Journal of Immunology, 2016
- Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitinationJournal of Experimental Medicine, 2016
- Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive ImmunotherapyACS Nano, 2015
- The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T CellsImmunity, 2015
- Nanoscale artificial antigen presenting cells for T cell immunotherapyNanomedicine: Nanotechnology, Biology and Medicine, 2014
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011
- Degradation of T Cell Receptor (TCR)–CD3-ζ Complexes after Antigenic StimulationJournal of Experimental Medicine, 1997